{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:55:50Z","timestamp":1791849350465,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"DOI":"10.1007\/s12149-026-02299-6","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:25:42Z","timestamp":1791825942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of left ventricular 18F-FDG PET\/CT derived parameters and uptake patterns for chemotherapy-induced cardiotoxicity in patients with lymphoma"],"prefix":"10.1007","author":[{"given":"Mai Huy","family":"Thong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4944-5137","authenticated-orcid":false,"given":"Mai Hong","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Ba","family":"Khoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Chun","family":"Paeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"2","key":"2299_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, et al. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56(2):185\u2013229.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"2299_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12967-018-1670-9","volume":"16","author":"M Sarocchi","year":"2018","unstructured":"Sarocchi M, et al. An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline. J Transl Med. 2018;16(1):295.","journal-title":"J Transl Med"},{"issue":"1","key":"2299_CR3","first-page":"17","volume":"9","author":"MMC Becker","year":"2023","unstructured":"Becker MMC, et al. Anthracycline cardiotoxicity: current methods of diagnosis and possible role of (18)F-FDG PET\/CT as a new biomarker. Cardiooncology. 2023;9(1):17.","journal-title":"Cardiooncology"},{"issue":"36","key":"2299_CR4","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768\u2013801.","journal-title":"Eur Heart J"},{"issue":"2","key":"2299_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0319442","volume":"20","author":"R Lin","year":"2025","unstructured":"Lin R, et al. The predictive value of changes in 18F-FDG PET\/CT cardiac uptake patterns and metabolic parameters for anthracycline based chemotherapy induced cardiac toxicity in lymphoma patients. PLoS ONE. 2025;20(2):e0319442.","journal-title":"PLoS ONE"},{"issue":"10","key":"2299_CR6","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1042\/CS20200301","volume":"135","author":"A Narezkina","year":"2021","unstructured":"Narezkina A, Narayan HK, Zemljic-Harpf AE. Molecular mechanisms of anthracycline cardiovascular toxicity. Clin Sci (Lond). 2021;135(10):1311\u201332.","journal-title":"Clin Sci (Lond)"},{"issue":"9","key":"2299_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","volume":"27","author":"JC Plana","year":"2014","unstructured":"Plana JC, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27(9):911\u201339.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"2299_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5603\/CJ.2013.0158","volume":"20","author":"Y Kang","year":"2013","unstructured":"Kang Y, et al. Early detection of anthracycline-induced cardiotoxicity using two-dimensional speckle tracking echocardiography. Cardiol J. 2013;20(6):592\u20139.","journal-title":"Cardiol J"},{"key":"2299_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9110372","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. Cardiac biomarkers for the detection and management of cancer therapy-related cardiovascular toxicity. J Cardiovasc Dev Dis. 2022. https:\/\/doi.org\/10.3390\/jcdd9110372.","journal-title":"J Cardiovasc Dev Dis"},{"key":"2299_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.120000","volume":"565","author":"W Feng","year":"2025","unstructured":"Feng W, et al. Early detection of anthracycline-induced cardiotoxicity. Clin Chim Acta. 2025;565:120000.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2299_CR11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.6004\/jnccn.2015.0075","volume":"13","author":"RT Hoppe","year":"2015","unstructured":"Hoppe RT, et al. Hodgkin lymphoma, version 2.2015. J Natl Compr Canc Netw. 2015;13(5):554\u201386.","journal-title":"J Natl Compr Canc Netw"},{"key":"2299_CR12","unstructured":"NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphomas. National Comprehensive Cancer Network. 2025. https:\/\/www.nccn.org\/patientguidelines."},{"issue":"41","key":"2299_CR13","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361.","journal-title":"Eur Heart J"},{"key":"2299_CR14","doi-asserted-by":"crossref","unstructured":"\u204e R.B.a.b., et al., [18F] FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 3.0. The EANM Journal, December 2025. Volume 1.","DOI":"10.1016\/j.eanmj.2025.100006"},{"issue":"6","key":"2299_CR15","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s12350-019-01617-y","volume":"27","author":"J Kim","year":"2020","unstructured":"Kim J, et al. Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity. J Nucl Cardiol. 2020;27(6):2154\u201363.","journal-title":"J Nucl Cardiol"},{"issue":"24","key":"2299_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/app142411653","volume":"14","author":"D Palomino-Fern\u00e1ndez","year":"2024","unstructured":"Palomino-Fern\u00e1ndez D, et al. Reduced homogeneous myocardial [18F]FDG uptake in routine PET\/CT studies as an early indicator of chemotherapy-induced cardiotoxicity. Appl Sci (Basel). 2024;14(24):11653.","journal-title":"Appl Sci (Basel)"},{"key":"2299_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072279","author":"A Haider","year":"2020","unstructured":"Haider A, et al. Myocardial (18)F-FDG uptake pattern for cardiovascular risk stratification in patients undergoing oncologic PET\/CT. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9072279.","journal-title":"J Clin Med"},{"issue":"10","key":"2299_CR18","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2967\/jnumed.117.191122","volume":"58","author":"M Bauckneht","year":"2017","unstructured":"Bauckneht M, et al. Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: a translational (18)F-FDG PET\/CT observation. J Nucl Med. 2017;58(10):1638\u201345.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02299-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02299-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02299-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:32:15Z","timestamp":1791847935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02299-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":18,"alternative-id":["2299"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02299-6","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mai Huy Thong, Mai Hong Son, Tran Ba Khoa and Jin Chun Paeng declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}